O.R. Ødegård

1.2k total citations
21 papers, 1.0k citations indexed

About

O.R. Ødegård is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, O.R. Ødegård has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in O.R. Ødegård's work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Atrial Fibrillation Management and Outcomes (4 papers). O.R. Ødegård is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Atrial Fibrillation Management and Outcomes (4 papers). O.R. Ødegård collaborates with scholars based in Norway and United Kingdom. O.R. Ødegård's co-authors include Ulrich Abildgaard, Mengqiu Li, Ulrik Abildgaard, Arne N. Teien, Magne K. Fagerhol, Maggie Miller-Andersson, Harald Arnesen, B. Ly, B. P. Berdal and Tom Bergan and has published in prestigious journals such as Thrombosis and Haemostasis, Thrombosis Research and Scandinavian Journal of Clinical and Laboratory Investigation.

In The Last Decade

O.R. Ødegård

21 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O.R. Ødegård Norway 13 620 213 198 178 167 21 1.0k
Ewa Marciniak United States 18 712 1.1× 207 1.0× 224 1.1× 209 1.2× 207 1.2× 37 1.2k
PW Majerus United States 13 848 1.4× 168 0.8× 255 1.3× 333 1.9× 96 0.6× 20 1.3k
J Niemetz United States 15 571 0.9× 182 0.9× 132 0.7× 97 0.5× 108 0.6× 34 1.0k
C. S. P. Jenkins France 17 740 1.2× 328 1.5× 191 1.0× 73 0.4× 143 0.9× 42 1.2k
A Capitanio Italy 16 893 1.4× 260 1.2× 182 0.9× 112 0.6× 202 1.2× 24 1.4k
M. J. Gallimore United Kingdom 22 589 0.9× 136 0.6× 140 0.7× 79 0.4× 238 1.4× 76 1.1k
J. N. Shanberge United States 16 321 0.5× 114 0.5× 132 0.7× 98 0.6× 234 1.4× 42 853
F Josso France 15 558 0.9× 189 0.9× 47 0.2× 70 0.4× 67 0.4× 73 845
N Yoshida Japan 15 358 0.6× 314 1.5× 69 0.3× 103 0.6× 53 0.3× 31 762
R. D. Langdell United States 13 631 1.0× 191 0.9× 78 0.4× 68 0.4× 90 0.5× 25 1.0k

Countries citing papers authored by O.R. Ødegård

Since Specialization
Citations

This map shows the geographic impact of O.R. Ødegård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O.R. Ødegård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O.R. Ødegård more than expected).

Fields of papers citing papers by O.R. Ødegård

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O.R. Ødegård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O.R. Ødegård. The network helps show where O.R. Ødegård may publish in the future.

Co-authorship network of co-authors of O.R. Ødegård

This figure shows the co-authorship network connecting the top 25 collaborators of O.R. Ødegård. A scholar is included among the top collaborators of O.R. Ødegård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O.R. Ødegård. O.R. Ødegård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berdal, B. P., et al.. (1982). DEMONSTRATION OF EXTRACELLULAR PROTEOLYTIC ENZYMES FROM LEGIONELLA SPECIES STRAINS BY USING SYNTHETIC CHROMOGENIC PEPTIDE SUBSTRATES. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 90B(1-6). 119–123. 5 indexed citations
2.
Berdal, B. P., et al.. (1982). Demonstration of extracellular proteolytic enzymes from Legionella species strains by using synthetic chromogenic peptide substrates.. 119–123. 10 indexed citations
3.
Ødegård, O.R., et al.. (1978). Automated Antithrombin III Assay with a Centrifugal Analyser. Pathophysiology of Haemostasis and Thrombosis. 7(4). 202–209. 4 indexed citations
4.
Ødegård, O.R. & Ulrich Abildgaard. (1978). Antithrombin III: Critical Review of Assay Methods. Pathophysiology of Haemostasis and Thrombosis. 7(2-3). 127–134. 29 indexed citations
5.
Ødegård, O.R. & Mengqiu Li. (1978). Simultaneous inactivation of thrombin and factor Xa by AT-III: Influence of heparin. Thrombosis Research. 12(4). 697–700. 6 indexed citations
6.
Ødegård, O.R. & Mengqiu Li. (1978). On Use of Chromogenic Substrates for Studies of Coagulation Inhibitors. Pathophysiology of Haemostasis and Thrombosis. 7(2-3). 121–126. 8 indexed citations
7.
Ødegård, O.R. & Ulrik Abildgaard. (1977). Antithrombin III: Critical Review of Assay Methods. Significance of Variations in Health and Disease. Thrombosis and Haemostasis. 43 indexed citations
8.
Ødegård, O.R. & Ulrich Abildgaard. (1977). Antifactor Xa Activity in Thrombophilia Studies in a Family with At‐III Deficiency. Scandinavian Journal of Haematology. 18(2). 86–90. 25 indexed citations
9.
Abildgaard, Ulrich, Mengqiu Li, & O.R. Ødegård. (1977). Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH). Thrombosis Research. 11(4). 549–553. 332 indexed citations
10.
Ødegård, O.R., Ulrich Abildgaard, Mengqiu Li, & Maggie Miller-Andersson. (1977). Inactivation of bovine and human thrombin and factor Xa by antithrombin III studied with amidolytic methods. Thrombosis Research. 11(2). 205–216. 22 indexed citations
11.
Ødegård, O.R. & Arne N. Teien. (1976). Antithrombin III, heparin cofactor and antifactor Xa in a clinical material. Thrombosis Research. 8(2). 173–178. 16 indexed citations
12.
Abildgaard, Ulrich, Mengqiu Li, & O.R. Ødegård. (1976). A Simple Amidolytic Method for the Determination of Functionally Active Antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigation. 36(1). 109–112. 36 indexed citations
13.
Abildgaard, Ulrich, Mengqiu Li, & O.R. Ødegård. (1976). A Simple Amidolytic Method for the Determination of Functionally Active Antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigation. 36(1). 109–112. 22 indexed citations
14.
Ødegård, O.R., Mengqiu Li, & Ulrich Abildgaard. (1976). Antifactor Xa Activity Measured with Amidolytic Methods. Pathophysiology of Haemostasis and Thrombosis. 5(5). 265–275. 66 indexed citations
15.
Ødegård, O.R., Magne K. Fagerhol, & Mengqiu Li. (1976). Heparin Cofactor Activity and Antithrombin III Concentration in Plasma Related to Age and Sex. Scandinavian Journal of Haematology. 17(4). 258–262. 25 indexed citations
16.
Abildgaard, Ulrich, Mengqiu Li, Arne N. Teien, & O.R. Ødegård. (1975). Coagulation Inhibitors Studied with Chromogenic Substrate. Thrombosis and Haemostasis. 4 indexed citations
17.
Ødegård, O.R., Mengqiu Li, & Ulrich Abildgaard. (1975). Heparin cofactor activity measured with an amidolytic method. Thrombosis Research. 6(4). 287–294. 291 indexed citations
18.
Ødegård, O.R.. (1975). Evaluation of an amidolytic heparin cofactor assay method. Thrombosis Research. 7(2). 351–360. 50 indexed citations
19.
Teien, Arne N., O.R. Ødegård, & Terje Christensen. (1975). Heparin coupled to albumin, dextran and ficoll: Influence on blood coagulation and platelets, and in vivo duration. Thrombosis Research. 7(2). 273–284. 9 indexed citations
20.
Arnesen, Harald, B. Ly, & O.R. Ødegård. (1973). Improved quantitation of serum FDP after coagulation at low pH. Thrombosis Research. 3(6). 643–655. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ewa Marciniak Breakdown of academic impact, for papers by PW Majerus Breakdown of academic impact, for papers by J Niemetz Breakdown of academic impact, for papers by C. S. P. Jenkins Breakdown of academic impact, for papers by A Capitanio Breakdown of academic impact, for papers by M. J. Gallimore Breakdown of academic impact, for papers by J. N. Shanberge Breakdown of academic impact, for papers by F Josso Breakdown of academic impact, for papers by N Yoshida Breakdown of academic impact, for papers by R. D. Langdell
Rankless by CCL
2026